These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24307697)

  • 21. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.
    Hernigou P; Poignard A; Beaujean F; Rouard H
    J Bone Joint Surg Am; 2005 Jul; 87(7):1430-7. PubMed ID: 15995108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique.
    Hernigou P; Mathieu G; Poignard A; Manicom O; Beaujean F; Rouard H
    J Bone Joint Surg Am; 2006 Sep; 88 Suppl 1 Pt 2():322-7. PubMed ID: 16951103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous autogenous bone marrow injection for delayed union or non union of fractures after internal fixation.
    Kassem MS
    Acta Orthop Belg; 2013 Dec; 79(6):711-7. PubMed ID: 24563979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.
    Hess DA; Levac KD; Karanu FN; Rosu-Myles M; White MJ; Gallacher L; Murdoch B; Keeney M; Ottowski P; Foley R; Chin-Yee I; Bhatia M
    Blood; 2002 Aug; 100(3):869-78. PubMed ID: 12130497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix.
    Schmökel HG; Weber FE; Seiler G; von Rechenberg B; Schense JC; Schawalder P; Hubbell J
    Vet Surg; 2004; 33(2):112-8. PubMed ID: 15027972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is platelet-rich plasma injection an effective choice in cases of non-union?
    Say F; Türkeli E; Bülbül M
    Acta Chir Orthop Traumatol Cech; 2014; 81(5):340-5. PubMed ID: 25514343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superior Potential of CD34-Positive Cells Compared to Total Mononuclear Cells for Healing of Nonunion Following Bone Fracture.
    Fukui T; Mifune Y; Matsumoto T; Shoji T; Kawakami Y; Kawamoto A; Ii M; Akimaru H; Kuroda T; Horii M; Yokoyama A; Alev C; Kuroda R; Kurosaka M; Asahara T
    Cell Transplant; 2015; 24(7):1379-93. PubMed ID: 24800622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Present day trends in the treatment of nonunion and delayed union in long bones.
    Gherlinzoni G; Vasciaveo F
    Bull Hosp Joint Dis; 1970 Oct; 31(2):141-9. PubMed ID: 5491943
    [No Abstract]   [Full Text] [Related]  

  • 30. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Extracorporeal shock wave therapy for delayed union of long bone fractures - preliminary results of a prospective cohort study].
    Beutler S; Regel G; Pape HC; Machtens S; Weinberg AM; Kremeike I; Jonas U; Tscherne H
    Unfallchirurg; 1999 Nov; 102(11):839-47. PubMed ID: 10551931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
    Worel N; Rosskopf K; Neumeister P; Kasparu H; Nachbaur D; Russ G; Namberger K; Witt V; Schloegl E; Zojer N; Linkesch W; Kalhs P; Greinix HT
    Transfusion; 2011 May; 51(5):968-75. PubMed ID: 20880037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health outcomes of delayed union and nonunion of femoral and tibial shaft fractures.
    Tay WH; de Steiger R; Richardson M; Gruen R; Balogh ZJ
    Injury; 2014 Oct; 45(10):1653-8. PubMed ID: 25062602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
    Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.
    Sosman JA; Stiff P; Moss SM; Sorokin P; Martone B; Bayer R; van Besien K; Devine S; Stock W; Peace D; Chen Y; Long C; Gustin D; Viana M; Hoffman R
    J Clin Oncol; 2001 Feb; 19(3):634-44. PubMed ID: 11157013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute kidney injury successfully treated with autologous granulocyte colony-stimulating factor-mobilized peripheral blood CD34-positive cell transplantation: A first-in-human report.
    Suzuki H; Ohtake T; Tsukiyama T; Morota M; Ishioka K; Moriya H; Mochida Y; Hidaka S; Sato T; Asahara T; Kobayashi S
    Stem Cells Transl Med; 2021 Sep; 10(9):1253-1257. PubMed ID: 33955678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteogenic protein-1 for long bone nonunion: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(6):1-57. PubMed ID: 23074475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
    Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local transplantation of granulocyte colony-stimulating factor-mobilized human peripheral blood mononuclear cells for unhealing bone fractures.
    Fukui T; Matsumoto T; Mifune Y; Shoji T; Kuroda T; Kawakami Y; Kawamoto A; Ii M; Kawamata S; Kurosaka M; Asahara T; Kuroda R
    Cell Transplant; 2012; 21(4):707-21. PubMed ID: 21929873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.
    Pusic I; Jiang SY; Landua S; Uy GL; Rettig MP; Cashen AF; Westervelt P; Vij R; Abboud CN; Stockerl-Goldstein KE; Sempek DS; Smith AL; DiPersio JF
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1045-1056. PubMed ID: 18721768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.